logo
Why and when did Medicare start?

Why and when did Medicare start?

Health Line10-07-2025
Medicare became law in 1965. It aimed to provide health coverage to United States citizens ages 65 and over. When first introduced, Medicare included only parts A and B. Additional parts have since expanded coverage.
Medicare celebrates its 60th anniversary in 2025. President Lyndon B. Johnson signed the program into law in 1965, and it began offering coverage in 1966.
In its first year, 19 million people enrolled in Medicare for their healthcare coverage. As of 2025, there are over 68 million enrollees in the program.
When Medicare first began, it included just Medicare Part A and Medicare Part B, and it covered only people ages 65 and over.
Over the years, additional parts — including Part C and Part D — have been added. Coverage has also expanded to include people under age 65 with certain disabilities and chronic conditions.
Overview of Medicare history
The following chart summarizes the history of Medicare. Read on to learn about these developments in more detail.
Years Developments
1912-1961 Campaigns for national healthcare led to recommendations for healthcare for those ages 65 and older.
1965 Medicare (parts A and B) and Medicaid became law.
1972 Medicare extended coverage to include people with disabilities on SSDI and those with ESRD.
1980s Medigap supplement plans standardized.
Hospice care added under Part A.
1990s Cost assistance programs, such as Extra Help and MSPs, created.
Medicare Part C (Medicare Advantage) launched.
2000s Cost assistance programs, such as Extra Help and MSPs, created.
Medicare Part C (Medicare Advantage) launched.
2010s: Free preventive care and screenings added.
Additional changes to Part C and D plan coverage rules.
2020s Campaigns for national healthcare led to recommendations for healthcare for those aged 65 and older.
What did people do for healthcare before Medicare?
Before Medicare, just over half of those ages 65 and older had hospital insurance, and many lacked coverage for surgeries or out-of-hospital doctor expenses. Private insurers often didn't cover older people who they considered high risk.
Federal or state programs existed but were limited in scope and eligibility. Even older adults with higher incomes faced significant financial challenges if they became seriously ill.
The idea of a national healthcare program originated more than 100 years ago, as far back as former President Teddy Roosevelt's 1912 presidential campaign.
A serious push for a program began in 1945 under former President Harry Truman. During his term, he called for a national healthcare plan and presented the idea to Congress. However, his proposals didn't make it through Congress at that time.
Which president started Medicare?
By the 1960s, the call for a national program was growing stronger. In 1961, former President John F. Kennedy created a task force recommending a program for people ages 65 and older.
On July 30, 1965, President Lyndon B. Johnson enacted the Medicare and Medicaid legislation.
When did Medicare A and B start?
When introduced in 1965, Medicare had only two parts: Medicare Part A and Medicare Part B. That's why you'll often see those two parts referred to as Original Medicare today.
Parts A and B looked pretty similar to the Original Medicare you may be familiar with, although the costs have changed over time. Just like today, Medicare Part A was hospital insurance, and Medicare Part B was medical insurance.
How much did Medicare cost in 1965?
Most people don't pay a premium for Part A, but need to pay one for Part B. In 1966, the monthly Part B premium was $3. By comparison, in 2025, it is $185.
When did Medicare start covering people with disabilities?
In 1972, former President Richard Nixon expanded Medicare coverage to include people with disabilities who received Social Security Disability Insurance. He also extended immediate coverage to people who had received a diagnosis of end stage renal disease (ESRD).
Later, in 2001, people with amyotrophic lateral sclerosis (ALS) also became eligible for Medicare before age 65. These expansions are still in effect today.
»Learn more: What to Know About Medicare Disability Coverage.
Hospice coverage
Medicare didn't initially cover hospice care for people with end stage diagnoses, but it added this coverage in 1982. Medicare Part A still offers hospice services today.
Cost-sharing
People used to pay the same amount for Medicare, regardless of income. Today, people from higher-income households might pay more, while people from lower-income households might pay less.
This change began in 1988 with the creation of programs to help enrollees from lower-income households pay for their Medicare premiums and other costs. Medicare added extra programs to help people pay for their Medicare coverage throughout the 1990s.
Some examples of these programs include the Extra Help program, which helps those from lower income households pay for their medications, and four different Medicare savings programs to help pay for premiums and other Medicare expenses.
In 2003, modifications to the Medicare Modernization Act led to the introduction of the Income-Related Monthly Adjustment Amount (IRMAA).
When did Medicare add Medicare Advantage plans?
The Balanced Budget Act of 1997 led to the introduction of Medicare Part C, with coverage beginning in 1999. Today, private insurance companies that contract with Medicare offer Medicare Part C plans, sometimes called Medicare Advantage.
Medicare Advantage plans work with a network of providers. Their coverage model is more similar to employer coverage than Original Medicare.
Today, these plans must offer at least the same coverage as Original Medicare, and they often include additional coverage for services that Medicare doesn't cover, like dental, vision, and prescription drug costs.
Part D
The Medicare Modernization Act, signed into law in 2003 by former President George W. Bush, also expanded Medicare and established Medicare Part D.
Part D is prescription drug coverage. Before Part D, Medicare didn't include this coverage. Part D officially took effect in 2006. Then, in 2010, former President Barack Obama signed the Affordable Care Act into law.
The law added Medicare coverage for preventive care and health screenings, making these services free for Medicare enrollees. It also changed some rules for private Medicare plans, such as Part C and Part D plans.
Beginning in 2023, all vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) became freely available to Medicare enrollees.
The Inflation Reduction Act's (IRA) Medicare Part D provisions also introduced a new cap on annual spending for prescription drugs. In 2025, this amount is $2,000, and contributions from the Medicare Extra Help program also count toward this limit. In addition, Part D enrollees can now get low cost insulin for $35 or less per month.
As part of the IRA, the Centers for Medicare & Medicaid (CMS) negotiated lower prices for certain costly drugs, starting with 10 initial Part D drugs for 2026. By 2027 and 2028, CMS will select up to 15 more drugs for negotiation under Part D or Part B.
Medigap
Medigap, also known as Medicare supplement insurance, helps you pay the out-of-pocket costs of Original Medicare, like copays and deductibles.
Private insurance companies sell these plans. However, starting in 1980, the federal government began regulating them to ensure they meet certain standards.
Currently, 10 Medigap plans are available: A, B, C, D, F, G, K, L, M, and N. In 1980, Medicare standardized coverage under each of these plans. This means that no matter where you live or what company you purchase a plan from, you'll be guaranteed the same basic coverage from each plan. For example, Medigap Plan A in Boston offers the same basic coverage as Medigap Plan A in Seattle.
That said, keep in mind that Medigap Plans C and F are no longer available to new Medicare enrollees who became eligible on or after January 1, 2020. This change results from the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015, which prevents new Medigap policies from covering the Medicare Part B deductible. However, if you were eligible for Medicare before January 1, 2020, you might still be able to enroll in these plans.
The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Rapid Sepsis Test Boosts ED Discharge Rates
Rapid Sepsis Test Boosts ED Discharge Rates

Medscape

time9 minutes ago

  • Medscape

Rapid Sepsis Test Boosts ED Discharge Rates

TOPLINE: A rapid host response sepsis test, IntelliSep, when implemented early in triage across emergency departments (EDs), led to a significant increase in discharge rates and hospital-free days. METHODOLOGY: Researchers integrated the IntelliSep host response test into the screening of 4650 patients who presented with signs of infection at four EDs in Louisiana and Mississippi between 2024 and 2025. The test measured leukocyte biophysical properties and generated an index (0.1-10.0) from whole blood within 10 minutes. Patients were stratified into three bands on the basis of the risk for sepsis: band 1 (low risk), band 2 (moderate risk), and band 3 (high risk). Screening was conducted through a nurse-driven triage protocol, followed by a physician-driven protocol, with treatment decisions guided by the test result. Outcomes were ED discharge rates, 30-day return visits, and return-adjusted hospital-free days. TAKEAWAY: Based on the test results, 54.8% of patients were classified as low-risk patients (band 1), 25.7% as intermediate-risk patients (band 2), and 19.6% as high-risk patients (band 3). From month 1 to month 4, ED discharge rates increased by 55.9% in patients with low risk (from 22.0% to 34.3%; P < .01) and by 78% in those with intermediate risk (from 10.5% to 18.7%; P < .05). Median return-adjusted hospital-free days increased by 1 day in the overall cohort (from 26.0 to 27.0 days; P < .0001), with a 1-day increase for low-risk patients (from 27.0 to 28.0 days; P < .0001) and a 2-day increase for high-risk patients (from 25.0 to 27.0 days; P < .05). ED return rates remained unchanged across all risk bands throughout the study period. Mortality rates among low-risk patients declined from 10.6% at month 1 to 6.3% at month 4 (P < .05). IN PRACTICE: "Improving quality of care in the ED required our health system to tackle sepsis — a time-sensitive condition that can be deadly if not addressed quickly. Rapid diagnostics like IntelliSep help our team make better treatment decisions," lead author Christopher Thomas, MD, Vice President and Chief Quality Officer at FMOLHS and critical care physician at LSU Health Sciences Center, said in a press release. "By ruling out sepsis for low-risk patients, we're reducing avoidable admissions and creating bed capacity for critically ill patients," the authors wrote. SOURCE: The study was led by Christopher Thomas, MD, Our Lady of the Lake Regional Medical Center, Baton Rouge, Los Angeles. The study was presented at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Clinical Lab Expo. LIMITATIONS: The 4-month rollout limits causal inference and long-term insights. Patients with missing discharge disposition data were excluded from the analysis, which may have affected the completeness of the results. DISCLOSURES: One of the study authors is affiliated with Cytovale Inc, the company that developed the IntelliSep test. The authors did not report any funding sources. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

New Lyme Blood Test Bests Standard Diagnostics
New Lyme Blood Test Bests Standard Diagnostics

Medscape

time9 minutes ago

  • Medscape

New Lyme Blood Test Bests Standard Diagnostics

A new blood test for Lyme disease outperforms standard diagnostic testing across all stages of the disease, according to new data presented at the 2025 Association for Diagnostics and Laboratory Medicine annual meeting in Chicago. The test, which pairs a multiplexed assay with a machine learning algorithm, showed over 90% accuracy in diagnosing Lyme disease in 308 human serum samples. The CDC estimates that about 476,000 individuals may be diagnosed and treated for Lyme disease each year in the US. The tick-borne disease, caused primarily by infection with Borrelia burgdorferi , is most treatable in the first few weeks of infection, but diagnosis during this early stage poses a challenge to clinicians. Barriers to Early Diagnosis The most common sign of early infection is a skin rash called erythema migrans (EM) that often occurs at the site of the tick bite. While a bull-eye-shaped rash is telltale sign of Lyme disease, this type of EM is actually not a common presentation, said Liz Horn, PhD, MBI, principal investigator of the Lyme Disease Biobank, a biorepository of samples from people with Lyme disease, headquartered in Portland, Oregon. She was not involved with the work. EMs can present in different forms, and about 30% of people with Lyme disease do not develop a rash. 'If you don't have a rash, you have to rely on serologic tests,' Horn said, which are notoriously insensitive in early disease, as antibodies can take weeks to develop. The CDC currently recommends a two-test format. Standard two-tier testing (STTT) involves an enzyme immunoassay as the first step, which, if positive or indeterminate, is followed by a Western Blot. In the first few weeks of disease, antibody levels can be too low to detect, leading to false negatives. In a recent study led by Horn using samples from individuals with signs and symptoms of early Lyme disease who were enrolled in the Lyme Disease Biobank, just 34% of patients presenting with EM > 5 cm tested positive on serologic tests. Among patients without EM, only 16% had positive results, and among those with EM ≤ 5 cm, the positivity rate dropped to just 5%. 'If we could get a serology test that works better in early disease, that could have great benefits for both patients and providers,' Horn said. Pairing AI With a Multiassay This new blood test, called LymeSeek, works differently by detecting 10 different antigens simultaneously. An algorithm developed using deep learning 'sorts through all of the responses,' explained Holly Ahern, MS, MT, the chief scientific officer of ACES Diagnostics, the company developing LymeSeek, in Paradise Valley, Arizona. 'That is what gives the test its very high sensitivity and specificity,' she said. Ahern is also an associate professor of microbiology at State University of New York at Adirondack (SUNY Adirondack) in Queensbury, New York. To validate the test, developers analyzed the human serum samples of 150 control individuals and 158 Lyme disease cases, across all phases of Lyme disease. Samples were provided by the Lyme Disease Biobank, the CDC, and the Johns Hopkins University Lyme Disease Research Center in Baltimore. The control samples were from patients in endemic and nonendemic areas and included individuals with non-Lyme look-like diseases, like mononucleosis and rheumatoid arthritis. The test correctly classified 281 samples as Lyme cases or control individuals, resulting in a test sensitivity of 91.7% and a specificity of 90.7%. In an additional analysis, the ACES diagnostics team also compared LymeSeek to STTT using samples from the Johns Hopkins Lyme Disease Research Center. In very early stages of disease (0-72 hours after appearance of an EM rash), LymeSeek diagnosed 100% of Lyme cases, whereas standard testing identified only 37% of cases. In samples taken 3-4 weeks after EM appearance, LymeSeek's results remained consistent, and standard testing identified 76% of cases. 'The observed seroconversion indicates the enrolled patients did have Lyme disease and is a confirmation that the test result given by LymeSeek is a true positive test result,' Ahern added. In patients with post-treatment Lyme disease (6 months or more after infection), LymeSeek identified 97% of cases, whereas standard testing identified less than half (46%). 'With this one single test, we can detect [Lyme] in the early stages, but we can also detect it across all stages of the disease' Ahern said, which includes through 1 year from first Lyme diagnosis. ACES Diagnostics is now working to develop a clinical trial plan with the FDA. The test has received a De Novo classification, meaning it's being evaluated on its own merits rather than compared to the current standard diagnostics. 'We're not just showing that we are as good as two-tier serology because what's the point of being as good as a test that really isn't very good?' Ahern said.

New Research Reveals Which Simple Health Changes Can Help Prevent Cognitive Decline
New Research Reveals Which Simple Health Changes Can Help Prevent Cognitive Decline

Yahoo

time13 minutes ago

  • Yahoo

New Research Reveals Which Simple Health Changes Can Help Prevent Cognitive Decline

A new study suggests that certain lifestyle changes can help keep older adults sharp as they ageNEED TO KNOW A new clinical trial suggests that certain healthy habits can help stave off mental decline in adults as they age The study analyzed the impact of two different two-year lifestyle interventions on over 2,000 older adults at a heightened risk of cognitive decline According to national data cited by researchers, up to 35% of older adults do not meet physical activity guidelines, while 81% have "suboptimal diets"A new study offers more solid evidence that certain healthy behaviors can help stave off mental decline in adults. Habits like improving diet, increasing exercise, monitoring cardiovascular health and experiencing cognitive challenges and social stimulation showed proven benefits in older adults. A clinical trial published on Monday, July 28, by JAMA Network studied the impact of two different two-year lifestyle interventions on 2,111 older adults who had a heightened risk of cognitive decline due to a sedentary lifestyle and poor diet, as well as "at least two additional criteria" linked to their family history of memory issues, higher cardiometabolic risk, race and ethnicity, age and sex. Those randomly assigned to a more structured lifestyle intervention attended 38 peer team meetings over the span of two years, and participated in aerobic, resistance and flexibility workouts. They also received guidelines about eating a healthy Mediterranean diet, completed online cognitive trainings and received specific health coaching from a medical advisor every six months about any abnormal laboratory results. Additionally, they were given monthly rebates of up to $10 for buying blueberries. Meanwhile, those in the self-guided lifestyle intervention group received more general encouragement about exercise, eating well and cognitive and social stimulation "without goal-directed coaching" during six peer team meetings throughout the two years, and were given $75 gift cards to support healthy behavioral changes. Researchers conducted cognitive assessments of the participants during clinic visits at baseline and every six months for two years. "Both interventions promoted increased physical and cognitive activity, healthy diet, social engagement, and cardiovascular monitoring but differed in structure, intensity, and accountability," the study's authors wrote. While researchers found both groups showed cognitive improvement throughout the study, those who participated in the structured intervention "yielded greater benefit" than the self-guided group, they noted. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. "Among older adults at risk of cognitive decline and dementia, a structured, higher-intensity intervention had a statistically significant greater benefit on global cognition compared with an unstructured, self-guided intervention," the authors added. The findings suggest a large number of people nationwide could benefit long-term by implementing the health changes analyzed in the trial. Its authors note, "National data indicate that up to 35% of older adults do not meet physical activity guidelines, 81% consume suboptimal diets, and nearly 55% meet criteria for metabolic syndrome." Read the original article on People

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store